Pharmafile Logo

TVF Communications

- PMLiVE

Pfizer’s Hympavzi receives EC approval to treat haemophilia A and B patients

The genetic blood disorder affects more than 800,000 people globally

- PMLiVE

Innovative Trials celebrates success for its groundbreaking Retention Patch Program

Innovative Trials attended the PME Award Gala Dinner last night (21st November 2024)

Innovative Trials

Ki Park of Genesis Research Group

Genesis Research Group unveils enhanced US market access data analytics

Genesis Research Group (“Genesis”), a pioneer of tech-enabled real-world evidence (RWE), health economics and outcomes research (HEOR), and market access services, announces the expansion of its real-world data analytics capabilities...

Genesis Research Group

- PMLiVE

EAACI launches first World Anaphylaxis Awareness Day

The day is aimed at raising awareness of severe allergic reaction, and promoting prevention and management

- PMLiVE

Pfizer appoints Chris Boshoff as chief scientific officer and president of R&D

Boshoff has most recently been serving as the company’s chief oncology officer and executive vice president

- PMLiVE

UCB’s Bimzelx granted FDA approval to treat hidradenitis suppurativa in adults

The inflammatory skin disease affects approximately one in every 100 people in the US

- PMLiVE

Bringing more effective storytelling to medical publications

By Nicole Parker, Kristen Quinn and Stephen Towers

- PMLiVE

Health Awareness V Health Anxiety: Is the increase of online health content a help or hindrance?

Medical Writer, Steph Gathercole, looks at the impact increased access to online health information has on the public through the lens of Anxiety

Mednet

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links